Jon also confirming they have had a number of discussions regarding licensing, takeover and that they are not going to decide until after the FDA meeting next month. (Presumably to get the best value/outcome). Also confirmed our theory that they will be prepared to fund 2 phase 3 without any capital raisings but the likelihood of a transaction occurring from then would be increased. 2 phase 3's is fantastic but there's an opportunity for much more to be occurring and for this drug to be a 10b+ sales monster.
Jon also confirming they have had a number of discussions...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.56 |
Change
0.000(0.00%) |
Mkt cap ! $1.860B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 74 | $15.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.84 | 368 | 2 |
View Market Depth
| Last trade - 09.59am 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable